About Schrein Pharma
Schrein Pharma is a Healthcare company. Specialization in paediatric, diabetic, and general medicines within the healthcare sector. Its Indian entity Schrein Pharma Private Limited reported revenue of ₹4.8 Lakh. Schrein Pharma offers products and services including Diabetic Medicines and Analgesic Tablets. Its focus areas include Therapeutics, General Medicines, Analgesics and Antibiotics and Pharmaceuticals.
Company details
Schrein Pharma is recognized for its focus on paediatric, diabetic, and general medicines, with operations established for over 11 years in the pharmaceutical industry. Quality products such as tablets, syrups, and injections are provided, adhering to WHO-GMP standards and covering therapies like diabetology and gastrology. The company is based in Chennai, India, where various healthcare segments are addressed to meet public needs without promotional emphasis. Its product range includes analgesics and antibiotics, ensuring reliable medicinal solutions are delivered.
- SectorsHealthcare
- Email••••••••
- Website schreinpharma.com
- Legal Name Schrein Pharma Private Limited
- Date of Incorporation 14 Mar, 2023
- Jurisdiction Coimbatore, Tamil Nadu, India
- Indian entity revenue₹4.8 Lakh
FY 2024
- Indian entity net loss-₹3.5 Lakh
FY 2024 · -75% margin
- Indian entity EBITDA-₹3.5 Lakh
FY 2024 · -75% margin
Associated legal entities of Schrein Pharma
Schrein Pharma operates through Schrein Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Schrein Pharma Private Limited CIN U46497TZ2023PTC027891 | Active | 14 Mar 2023 | Coimbatore, Tamil Nadu | ₹0.0 Cr | 2 | View details |
Products & Services of Schrein Pharma
Schrein Pharma offers a comprehensive portfolio of products and services, including Diabetic Medicines and Analgesic Tablets.
Medicines for diabetic management are supplied, including tablets and syrups tailored to related health needs.
Tablets and injections for pain relief are offered, covering analgesic and anti-inflammatory applications.
Board of directors of Schrein Pharma Private Limited (Schrein Pharma)
Schrein Pharma Private Limited is the primary company behind Schrein Pharma. The board of Schrein Pharma Private Limited currently have 2 directors; the longest-serving is Muniyappan Vijayakumar, appointed in 2023. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Muniyappan Vijayakumar DIN 10129332 | Director | 25 Apr 2023 | 3 yrs 6 mo | Schrein Pharma Private Limited |
| Rajkumar DIN 10131616 | Director | 25 Apr 2023 | 3 yrs 6 mo | Schrein Pharma Private Limited |
Financials of Schrein Pharma
Figures of Schrein Pharma Private Limited, the primary company behind Schrein Pharma, for FY 2024. Revenue was ₹4.8 Lakh. Net loss was -₹3.5 Lakh (-75% margin). EBITDA was -₹3.5 Lakh (-75% margin).
- ₹4.8 LakhRevenue · FY 2024
- -₹3.5 LakhNet loss · -75% margin
- -₹3.5 LakhEBITDA · -75% margin
- ₹10.5 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Schrein Pharma Private Limited are on its company page.
Detailed financial statements for Schrein Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Schrein Pharma
The primary company behind Schrein Pharma, Schrein Pharma Private Limited, reported revenue of ₹4.8 Lakh for FY 2024.
Schrein Pharma is recognized for its focus on paediatric, diabetic, and general medicines, with operations established for over 11 years in the pharmaceutical industry. Quality products such as tablets, syrups, and injections are provided, adhering to WHO-GMP standards and covering therapies like diabetology and gastrology. The company is based in Chennai, India, where various healthcare segments are addressed to meet public needs without promotional emphasis. Its product range includes analgesics and antibiotics, ensuring reliable medicinal solutions are delivered.
Schrein Pharma offers Diabetic Medicines and Analgesic Tablets.
Schrein Pharma operates through Schrein Pharma Private Limited.
The legal entities of Schrein Pharma currently have 2 directors, including Muniyappan Vijayakumar, Rajkumar.